… their tool outperformed other scientific methods, and they have applied for a U.S. patent. The National Institutes of Health and Wilmot Cancer Institute/Roswell Park Cancer Institute Collaboration Pilot Funds supported the research. Chief …
Category: Prostate Cancer
Lasers a transforma prostate treatment
The approach, tested across Europe, uses lasers and a drug made from deep sea bacteria to eliminate tumours, but without causing severe side effects. Trials on 413 men published in The Lancet Oncology showed nearly half of them had no remaining trace of cancer.
Prostate cancer laser therapy ‘huge leap forward’
A drug activated by laser light which successfully destroys early prostate cancer while avoiding surgery side effects has been labelled a “huge leap” forward. Trial results reflected favourably on the new technique, called vascular-targeted photodynamic therapy , in comparison to standard prostate cancer care.
Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424
Threshold Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for cancer, today announced that it has entered into a collaboration with the National Cancer Institute , part of the National Institutes of Health , to study TH-3424, the company’s new drug candidate for the treatment of cancer. The collaboration will explore the effects of TH-3424 against T-cell acute lymphoblastic leukemia xenograft cell lines with high AKR1C3 expression.
Cancer death rates two to nine times higher in the Caribbean compared to US
PORT OF SPAIN, Trinidad — In a recent study, researchers from the Caribbean Public Health Agency and the US Centers for Disease Control and Prevention found that the rates of death from cervical cancer, breast, prostate and colon cancer are two to nine times higher in the Caribbean compared to the United States. Only lung cancer was higher in the USA.